Welcome to our dedicated page for Capitalworks Emng Mkts Acqstn SEC filings (Ticker: CMCWF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Capitalworks Emng Mkts Acqstn's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Capitalworks Emng Mkts Acqstn's regulatory disclosures and financial reporting.
Piermont Valley Acquisition Corp, a Cayman Islands SPAC, filed its annual report describing its status, risks and plans to complete a merger before March 3, 2027. The company has repeatedly extended its deadline and, after several large redemption rounds, now has 5,954,449 Class A shares and 1 Class B share outstanding.
The report highlights a pending business combination with Tigerless Health via a multi-step merger into a new Nevada holding company, where former Tigerless stockholders are expected to own a majority. As of March 31, 2026, the trust account is anticipated to be about $12.02 per public share, and if no deal is completed by the deadline the SPAC will liquidate and redeem public shares.
Terms include up to $100 million of stock-based earn-out for Tigerless holders tied to multi-year performance milestones and a targeted PIPE raise of at least $5 million, which is not yet committed. The filing also notes prior termination of a Lexasure transaction and the company’s 2024 delisting from Nasdaq after missing the 36‑month business combination window.
Piermont Valley Acquisition Corp, a Cayman Islands SPAC, filed its annual report describing its status, risks and plans to complete a merger before March 3, 2027. The company has repeatedly extended its deadline and, after several large redemption rounds, now has 5,954,449 Class A shares and 1 Class B share outstanding.
The report highlights a pending business combination with Tigerless Health via a multi-step merger into a new Nevada holding company, where former Tigerless stockholders are expected to own a majority. As of March 31, 2026, the trust account is anticipated to be about $12.02 per public share, and if no deal is completed by the deadline the SPAC will liquidate and redeem public shares.
Terms include up to $100 million of stock-based earn-out for Tigerless holders tied to multi-year performance milestones and a targeted PIPE raise of at least $5 million, which is not yet committed. The filing also notes prior termination of a Lexasure transaction and the company’s 2024 delisting from Nasdaq after missing the 36‑month business combination window.
Tigerless Health, Inc., a New York-based Insurtech platform, has agreed to a definitive business combination with Piermont Valley Acquisition Corp., a publicly traded SPAC, valuing Tigerless Health at an enterprise value of approximately $280 million.
After closing, the combined company is expected to be renamed Tigerless AI Holdings, Inc. and listed on NASDAQ, with all existing Tigerless Health shareholders rolling 100% of their equity. The deal is intended to support continued investment in the company’s proprietary AI capabilities that help consumers understand and navigate insurance.
The boards of both companies have unanimously approved the transaction, which is expected to close in the second half of 2026, subject to shareholder and regulatory approvals and other customary closing conditions. Founder and CEO Zikang Wu and his management team are expected to continue leading the combined company.
Tigerless Health, Inc., a New York-based Insurtech platform, has agreed to a definitive business combination with Piermont Valley Acquisition Corp., a publicly traded SPAC, valuing Tigerless Health at an enterprise value of approximately $280 million.
After closing, the combined company is expected to be renamed Tigerless AI Holdings, Inc. and listed on NASDAQ, with all existing Tigerless Health shareholders rolling 100% of their equity. The deal is intended to support continued investment in the company’s proprietary AI capabilities that help consumers understand and navigate insurance.
The boards of both companies have unanimously approved the transaction, which is expected to close in the second half of 2026, subject to shareholder and regulatory approvals and other customary closing conditions. Founder and CEO Zikang Wu and his management team are expected to continue leading the combined company.